|
1. |
論文 |
Phase I/IIa clinical trial of therapeutic angiogenesis using hepatocyte growth factor gene transfer to treat critical limb ischemia. Arterioscler Thromb Vasc Biol 31(3),713-20頁 （共著） 2011/03 |
|
2. |
論文 |
Regression of abdominal aortic aneurysms by simultaneous inhibition of nuclear factor kappaB and ets in a rabbit model. Circulation Research 101(11),1175-1184頁 （共著） 2007 |
|
3. |
論文 |
Inhibition of experimental abdominal aortic aneurysm in the rat by use of decoy oligodeoxynucleotides suppressing activity of NFkB and ets transcription factors. Circulation 109,132-138頁 （共著） 2004 |
|
4. |
論文 |
Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets. Gene Therapy 7,417-427頁 （共著） 2000 |
|
5. |
論文 |
In Vivo Transfection of cis element "decoy" against NFkB binding site prevented myocardial infarction as gene therapy. Nature Medicine 3,894-899頁 （共著） 1997 |
|
6. |
論文 |
Moxibustion Promotes Formation of Granulation in Wound Healing Process through Induction of TGF-β. Chin J Integr Med 26(1),26-32頁 （共著） 2020 |
|
7. |
論文 |
Beneficial Effect of Laughter Therapy on Physiological and Psychological Function in the Elderly. 6(1),93-99頁 （共著） 2018 |
|
8. |
論文 |
Electric field exposure improves subjective symptoms related to sleeplessness in college students: A pilot study of electric field therapy for sleep disorder. Immunology 17 （共著） 2017 |
|
9. |
論文 |
Therapeutic effect of intra-articular injection of ribbon-type decoy oligonucleotides for hypoxia inducible factor-1 on joint contracture in an immobilized knee animal model. J Gene Med 18(8),180-92頁 （共著） 2016 |
|
10. |
論文 |
Wound healing potential of lavender oil by acceleration of granulation and wound contraction through induction of TGF-β in a rat model. BMC Complement Altern Med 26(16),144頁 （共著） 2016 |
|
11. |
論文 |
Continuous infusion of angiotensin Ⅱ modulates hypertrophic differentiation and apoptosis of chondrocytes in cartilage formation in a fracture model mouse. Hypertens Res 38(6),382-393頁 （共著） 2015 |
|
12. |
論文 |
Effect of Angiotensin Ⅱ Receptor Blocker, Olmesartan, on Turnover of Bone Metabolismin Bedridden Elderly Hypertensive Women with Disuse Syndrome. Geriatr Gerontol Int. 15(8),1064-72頁 （共著） 2015 |
|
13. |
論文 |
Anti-Apoptotic Effect of Human Telomerase Reverse Transcriptase on Endothelial Cells under Oxidative Stress, Independent of Telomere Elongation and Telomerase Activity. Immunology 13(2),112-121頁 （共著） 2013 |
|
14. |
論文 |
Anti-inflammatory Effect of Electro-acupuncture via Reduction in Colonic Peristalsis in a Mouse Model of Inflammatory Bowel Disease. Immunology 13(2),122-131頁 （共著） 2013 |
|
15. |
論文 |
Therapeutic effect of ribbon-type nuclear factor-κB decoy oligonucleotides in a rat model of inflammatory bowel disease. Curr Gene Ther 12(6),484-92頁 （共著） 2012/12 |
|
16. |
論文 |
Long-term follow-up evaluation of results from clinical trial using hepatocyte growth factor gene to treat severe peripheral arterial disease. Arterioscler Thromb Vasc Biol 32(10),2503-9頁 （共著） 2012/10 |
|
17. |
論文 |
Long-term follow-up evaluation of results from clinical trial using hepatocyte growth factor gene to treat severe peripheral arterial disease. Arterioscler Thromb Vasc Biol 31(3),713-20頁 （共著） 2011/03 |
|
18. |
論文 |
Systemic Administration of Ribbon-type Decoy Oligodeoxynucleotide Against Nuclear Factor κB and Ets Prevents Abdominal Aortic Aneurysm in Rat Model. Mol Ther 19(1),181-7頁 （共著） 2011/01 |
|
19. |
論文 |
Reno-vascular Hypertension is a Severe Risk Factor for Development of Abdominal Aortic Aneurysm. 森ノ宮医療大学紀要 (2号) （共著） 2010 |
|
20. |
論文 |
Inhibition of development of experimental aortic abdominal aneurysm in rat model by atorvastatin through inhibition of macrophage migration. Atherosclerosis 202(1),34-40頁 （共著） 2009 |
|
21. |
論文 |
Long-term follow up of initial clinical cases with NF-kappaB decoy oligodeoxynucleotide transfection at the site of coronary stenting. J Gene Med 10(7),805-9頁 （共著） 2008/07 |
|
22. |
論文 |
Inhibition of anastomotic intimal hyperplasia using a chimeric decoy strategy against NFkappaB and E2F in a rabbit model. Cardiovascular Research 79(4),706-714頁 （共著） 2008 |
|
23. |
論文 |
Inhibition of experimental abdominal aortic aneurysm in a rat model by the angiotensin receptor blocker valsartan. International Journal of Molecular Medicine 22(6),703-708頁 （共著） 2008 |
|
24. |
論文 |
Improvement of survival of skin flaps by combined gene transfer of hepatocyte growth factor and prostacyclin synthase. Journal of Gene Medicine 9(12),1087-1094頁 （共著） 2007 |
|
25. |
論文 |
Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy. Gene Ther 13(16),1206-13頁 （共著） 2006/08 |
|
26. |
論文 |
Model of vasculogenesis from embryonic stem cells for vascular research and regenerative medicine. Hypertension. 48(1),112-9頁 （共著） 2006/07 |
|
27. |
論文 |
Hypertension accelerated experimental abdominal aortic aneurysm through upregulation of nuclear factor kappaB and Ets. Hypertension 48(4),628-636頁 （共著） 2006 |
|
28. |
論文 |
Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model. Journal of Molecular Cellular Cardiology 41(3),431-440頁 （共著） 2006 |
|
29. |
論文 |
Prevention of abdominal aortic aneurysms by simultaneous inhibition of NFkappaB and ets using chimeric decoy oligonucleotides in a rabbit model. Gene Therapy 13(8),695-704頁 （共著） 2006 |
|
30. |
論文 |
Hepatocyte growth factor gene therapy reduces ventricular arrhythmia in animal models of myocardial ischemia. Acta Med Okayama. 59(3),73-8頁 （共著） 2005/06 |
|
31. |
論文 |
Development of novel method of non-viral efficient gene transfer into neonatal cardiac myocytes. Journal of Molecular Cellular Cardiology 39(3),503-509頁 （共著） 2005 |
|
32. |
論文 |
Inhibition of ets, an essential transcription factor for angiogenesis, to prevent the development of abdominal aortic aneurysm in a rat model. Gene Therapy 12(14),1109-1118頁 （共著） 2005 |
|
33. |
論文 |
Development of efficient plasmid DNA transfer into adult rat central nervous system using microbubble-enhanced ultrasound. Gene Ther 11(20),1532-9頁 （共著） 2004/10 |
|
34. |
論文 |
Effect of nifedipine on endothelial function in normotensive smokers: potential contribution of increase in circulating hepatocyte growth factor. J Hum Hypertens. 18(10),701-5頁 （共著） 2004/10 |
|
35. |
論文 |
Local delivery of E2F decoy oligodeoxynucleotides using ultrasound with microbubble agent (Optison) inhibits intimal hyperplasia after balloon injury in rat carotid artery model. Biochem Biophys Res Commun. 317(2),508-14頁 （共著） 2004/04 |
|
36. |
論文 |
Novel therapeutic strategy to treat brain ischemia: overexpression of hepatocyte growth factor gene reduced ischemic injury without cerebral edema in rat model. Circulation. 109(3),424-31頁 （共著） 2004/01 |
|
37. |
論文 |
In vivo evidence of angiogenesis induced by transcription factor, ets-1: ets-1 is located upstream of angiogenesis cascade. Circulation 109,3035-3041頁 （共著） 2004 |
|
38. |
論文 |
Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease by therapeutic angiogenesis. Hypertension 44(2),203-209頁 （共著） 2004 |
|
39. |
論文 |
Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model. Circulation. 108(18),2250-7頁 （共著） 2003/11 |
|
40. |
論文 |
Enhanced angiogenesis and improvement of neuropathy by cotransfection of human hepatocyte growth factor and prostacyclin synthase gene. FASEB J 17(6),779-81頁 （共著） 2003/04 |
|
41. |
論文 |
Angiogenic property of hepatocyte growth factor is dependent on upregulation of essential transcription factor for angiogenesis, ets-1. Circulation 107(10),1411-7頁 （共著） 2003/03 |
|
42. |
論文 |
Inhibition of NFkappaB activation using cis-element 'decoy' of NFkappaB binding site reduces neointimal formation in porcine balloon-injured coronary artery model. Gene Ther. 10(4),356-64頁 （共著） 2003/02 |
|
43. |
論文 |
HVJ-envelope vector for gene transfer into central nervous system. Biochem Biophys Res Commun 300(2),464-71頁 （共著） 2003/01 |
|
44. |
論文 |
Increase in peripheral blood flow by intravenous administration of prostaglandin E1 in patients with peripheral arterial disease, accompanied by up-regulation of hepatocyte growth factor (HGF). Hypertension Research 27,85-91頁 （共著） 2003 |
|
45. |
論文 |
Impaired endothelial dysfunction in diabetes mellitus rats was restored by oral administration of prostaglandin I2 analogue. J Endocrinol 175(1),217-23頁 （共著） 2002/10 |
|
46. |
論文 |
Mitogenic activity of oxidized lipoprotein (a) on human vascular smooth muscle cells. Hypertension 40(3),310-4頁 （共著） 2002/09 |
|
47. |
論文 |
Hepatocyte growth factor prevents endothelial cell death through inhibition of bax translocation from cytosol to mitochondrial membrane. Diabetes 51(8),2604-11頁 （共著） 2002/08 |
|
48. |
論文 |
Molecular strategy using cis-element 'decoy' of E2F binding site inhibits neointimal formation in porcine balloon-injured coronary artery model. Gene Ther 9(8),488-94頁 （共著） 2002/04 |
|
49. |
論文 |
Gene transfer of hepatocyte growth factor to subarachnoid space in cerebral hypoperfusion model. Hypertension 39(5),1028-34頁 （共著） 2002/03 |
|
50. |
論文 |
Impairment of collateral formation in lipoprotein(a) transgenic mice: therapeutic angiogenesis induced by human hepatocyte growth factor gene. Circulation 105(12),1491-6頁 （共著） 2002/03 |
|
51. |
論文 |
Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation. 105(10),1233-9頁 （共著） 2002/03 |
|
52. |
論文 |
Angiogensis and anti-fibrotic action by hepatocyte growth factor in cardiomyopathic hamster. Hypertension 40,47-53頁 （共著） 2002 |
|
53. |
論文 |
Effective transfection of a cis element "decoy" of the nuclear factor-kappaB binding site into the experimental choroidal neovascularization. Curr Eye Res 24,465-473頁 （共著） 2002 |
|
54. |
論文 |
Prevention and regression of atopic dermatitis by ointment containing NF-kB decoy oligodeoxynucleotides in NC/Nga atopic mouse model. Gene Therapy 9,1221-1229頁 （共著） 2002 |
|
55. |
論文 |
cis Element decoy against nuclear factor-kappaB attenuates development of experimental autoimmune myocarditis in rats. Circ Res 89(10),899-906頁 （共著） 2001/11 |
|
56. |
論文 |
Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D-glucose in human endothelial cells. Diabetes 50(6),1472-81頁 （共著） 2001/06 |
|
57. |
論文 |
Inhibition of neointima by angiotensin-converting enzyme inhibitor in porcine coronary artery balloon-injury model. Hypertension. 37(2),270-4頁 （共著） 2001/02 |
|
58. |
論文 |
Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells. Hypertension. 37((2 Pt 2)),581-6頁 （共著） 2001/02 |
|
59. |
論文 |
Endothelial apoptosis induced by oxidative stress through activation of NFkB: anti-apoptotic effect of antioxidant agents on endothelial cells. Hypertension 38,48-55頁 （共著） 2001 |
|
60. |
論文 |
Inhibition of neointimal formation after balloon injury by cilostazol, accompanied by improvement of endothelial dysfunction and induction of hepatocyte growth factor in rat diabetes model. Diabetologia 44,1034-1042頁 （共著） 2001 |
|
61. |
論文 |
Therapeutic angiogenesis induced by hepatocyte growth factor: potential gene therapy for ischemic diseases. Journal of Atherosclerosis and Thrombosis 7,71-76頁 （共著） 2001 |
|
62. |
論文 |
Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hind limb ischemia models: preclinical study for treatment of peripheral arterial disease. Gene Therapy 8,181-189頁 （共著） 2001 |
|
63. |
論文 |
Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: molecular mechanisms of delayed angiogenesis in diabetes. Circulation 104,2344-2350頁 （共著） 2001 |
|
64. |
論文 |
Anti-apoptotic action of hepatocyte growth factor through mitogen-activated protein kinase on human aortic endothelial cells. J Hypertens 18(10),1411-20頁 （共著） 2000/10 |
|
65. |
論文 |
In vivo transfer of human hepatocyte growth factor gene accelerates re-endothelialization and inhibits neointimal formation after balloon injury in rat model. Gene Ther 7(19),1664-71頁 （共著） 2000/10 |
|
66. |
論文 |
Catheter-delivered in vivo gene transfer into rat myocardium using the fusigenic liposomal mediated method. Japanese Heart Journal 41(5),633-47頁 （共著） 2000/09 |
|
67. |
論文 |
Ribozyme oligonucleotides against transforming growth factor-beta inhibited neointimal formation after vascular injury in rat model: potential application of ribozyme strategy to treat cardiovascular disease. Circulation 102(11),1308-14頁 （共著） 2000/09 |
|
68. |
論文 |
Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation. Circ Res 86(9),974-81頁 （共著） 2000/05 |
|
69. |
論文 |
Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21. Hypertension 35(1 Pt 2),237-43頁 （共著） 2000/01 |
|
70. |
論文 |
In vivo evidence of importance of cardiac angiotensin converting enzyme in the pathogenesis of cardiac hypertrophy. Arteriosclerosis 20,428-434頁 （共著） 2000 |
|
71. |
論文 |
Transfection of antisense p53 tumor suppressor gene oligodeoxynucleotides into rat carotid artery resulted in abnormal growth of vascular smooth muscle cells. Circulation 101,1447-1452頁 （共著） 2000 |
|
72. |
論文 |
Inhibition of the p53 tumor suppressor gene resulted in growth of human aortic vascular smooth muscle cells (VSMC): potential role of p53 in regulation of VSMC growth. Hypertension 34,192-200頁 （共著） 1999 |
|
73. |
論文 |
Transcription factor decoy for nuclear factor-kappaB inhibits tumor necrosis factor-alpha-induced expression of interleukin-6 and intracellular adhesion molecule-1 in endothelial cells. J Hypertens 16(7),993-1000頁 （共著） 1998/07 |
|
74. |
論文 |
Antisense Cdk2 kinase oligodeoxynucleotide inhibits ICAM-1 expression in murine cardiac allograft arteriopathy. Transplant Proc. 30(1),89-90頁 （共著） 1998/02 |
|
75. |
論文 |
Inhibition of growth of human vascular smooth muscle cells by overexpression of p21 gene through induction of apoptosis. Hypertension 31(1 Pt 2),493-8頁 （共著） 1998/01 |
|
76. |
論文 |
Inhibition of intimal hyperplasia after vein grafting by in vivo transfer of human senescent cell-derived inhibitor-1 gene. Gene Ther 5(6),761-9頁 （共著） 1998/01 |
|
77. |
論文 |
Role of hepatocyte growth factor in endothelial regulation: prevention of high D-glucose-induced endothelial cell death by prostaglandins and phosphodiesterase type 3 inhibitor. Diabetologia 40(9),1053-61頁 （共著） 1997/09 |
|
78. |
論文 |
Prevention of graft coronary arteriosclerosis by antisense cdk2 kinase oligonucleotide. Nat Med 3(8),900-3頁 （共著） 1997/08 |
|
79. |
論文 |
Potential role of an endothelium-specific growth factor, hepatocyte growth factor, on endothelial damage in diabetes. Diabetes. 46(1),138-42頁 （共著） 1997/01 |
|
80. |
論文 |
Efficient in vivo gene transfer into heart in rat myocardial infarction model using HVJ (Hemagglutinating Virus of Japan)-liposome method. Journal of Molecular and Cellular Cardiology 29,949-959頁 （共著） 1997 |
|
81. |
論文 |
Potential role of a novel vascular modulator, hepatocyte growth factor (HGF), in cardiovascular disease: characterization and regulation of local HGF system. J Atheroscler Thromb 4(1),12-9頁 （共著） 1997 |
|
82. |
論文 |
Serum deprivation induced apoptosis accompanied by up-regulation of p53 and bax in human aortic vascular smooth muscle cells. Heart & Vessels S12,71-75頁 （共著） 1997 |
|
83. |
論文 |
Survival of grafts of genetically modified cardiac myocytes transfected with FITC-labeled oligodeoxynucleotides and b-galactosidase gene in non-infarcted area, but not myocardial infarcted area. Gene Therapy 4,120-127頁 （共著） 1997 |
|
84. |
論文 |
Efficient oligonucleotide delivery using the HVJ-liposome method in the central nervous system. Am J Physiol 271(5 Pt 2),R1212-20頁 （共著） 1996/11 |
|
85. |
論文 |
Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor. J Hypertens. 14(9),1067-72頁 （共著） 1996/09 |
|
86. |
論文 |
Sustained transgene expression by transfection of renin gene into liver of neonates. Biochem Biophys Res Commun 224(1),43-9頁 （共著） 1996/07 |
|
87. |
論文 |
In vivo gene transfer of insulin gene into neonatal rats by the HVJ-liposome method resulted in sustained transgene expression. Gene Ther 3(6),477-82頁 （共著） 1996/06 |
|
88. |
論文 |
Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells. Biochem Biophys Res Commun 220(3),539-45頁 （共著） 1996/03 |
|
89. |
論文 |
Role of transcriptional cis-elements, angiotensinogen gene-activating elements, of angiotensinogen gene in blood pressure regulation. Hypertension 27(3 Pt 2),502-7頁 （共著） 1996/03 |
|
90. |
論文 |
In vivo transfer of gene and oligodeoxynucleotides into skin of fetal rats by incubation in amniotic fluid. Gene Therapy 3,878-885頁 （共著） 1996 |
|
91. |
論文 |
Novel strategy of gene therapy in cardiovascular disease with HVJ-liposome method. Contrib Nephrol 118,254-64頁 （共著） 1996 |
|
92. |
論文 |
Effect of angiotensinogen on blood pressure regulation in normotensive rats: application of a loss of function approach. J Hypertens 13(12 Pt 2),1767-74頁 （共著） 1995/12 |
|
93. |
論文 |
Transient decrease in high blood pressure by in vivo transfer of antisense oligodeoxynucleotides against rat angiotensinogen. Hypertension 26(1),131-6頁 （共著） 1995/07 |
|
5件表示
|
|
全件表示(93件)
|
